With nearly 10,000 square meters of laboratory facilities and qualifications in NMPA GLP 8, AAALAC international accreditation, and biological safety BSL-2 laboratories, Anling (Shenzhen) provides solid technical support for pharmaceutical research and development. Through professional services, it strengthens the biopharmaceutical research and development industry chain, promotes industry development, and helps build an internationally influential science and innovation center in the Guangdong-Hong Kong-Macao Greater Bay Area.
 
ZSHK has established pre-clinical GLP platforms, which include Anling Biomed (Suzhou) Co. Ltd. and Anling Biomed (Shenzhen) Co. Ltd. The company also possesses primate breeding and dog breeding facilities, allowing them to provide high-quality experimental non-human primates and dogs with clear and complete genealogy records and high-end animal models. They are capable of undertaking new drug evaluation projects that meet national and international standards, including drug efficacy screening, testing, metabolic studies, and safety evaluations. ZSHK's primary clients include new drug R&D enterprises, generic drug production enterprises, and chemical R&D and production enterprises. They offer pre-clinical research and technical support involving chemical drugs, biological drugs, Chinese medicine, medical devices, cell therapy products, and the chemical industry.